Skip to content

An exploratory randomized controlled study of electroacupuncture for chronic coronary syndrome based on acupoint sensitization theory

An exploratory randomized controlled study of electroacupuncture for chronic coronary syndrome based on acupoint sensitization theory

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000467
Enrollment
Unknown
Registered
2024-09-22
Start date
2024-08-27
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic coronary syndrome

Interventions

Sensitized site treatment group:The patient was treated with electroacupuncture on the basis of conventional drug treatment and the stimulation sites were 4 sensitized sites in the inner left arm. The
Conventional acupuncture group:On the basis of conventional western medicine treatment, the patient was treated with electroacupuncture. The stimulation sites were left Neiguan, Tongli, Cleft men and
Waiting group:The patients were treated with conventional drugs and no intervention was performed during 4 weeks of treatment and 4 weeks of follow-up.

Sponsors

Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) In accordance with the diagnostic criteria for chronic coronary syndrome (European Society of Cardiology (ESC) published in 2019 "Diagnosis and Guidelines for Chronic Coronary Syndrome") [5] ; (2) Ambulatory or inpatient patients who respond clearly and meet the above diagnostic criteria; (3) Age between 18 and 65 years;(4)Have a history of angina pectoris at least 2 times per week and the degree and duration of each episode are basically stable;(5) Patients who have not received the corresponding acupuncture treatment in almost 3 months;(6) A person who wishes to participate in the trial and signs an informed consent form. Note: Patients who meet the above six criteria can only be included in this study.

Exclusion criteria

Exclusion criteria: (1)Previous myocardial infarction serious heart failure valvular heart disease serious arrhythmias primary cardiomyopathy or hematologic disorders; People with pre-existing high blood pressure and high blood sugar; And those with other serious cerebrovascular diseases. (2) People with abnormal nerve sensation in the local skin endings; (3) Pregnant and lactating women patients with mental illness; (4) People with other serious heart and brain conditions; (5)Participate in other clinical trials at the same time; (6) People with bleeding or allergies. Note: Any compliance with any of the above paragraphs is excluded.

Design outcomes

Primary

MeasureTime frame
Frequency of angina attacks;

Secondary

MeasureTime frame
6min walking distance;(SAS\SDS);Changes in pain threshold;VAS score of pain degree at onset of strangulation;Seattle angina questionnaire;The duration of each attack of angina;????;

Countries

China

Contacts

Public ContactQiao Haifa

Shaanxi University of Traditional Chinese Medicine

1511006@sntcm.edu.cn18220046518

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026